Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

Sung GCY, Au Yeung SL, Zhao SS

Open source

DOI
10.3899/jrheum.2026-0574
Published
2026 Sep 1
Container
The Journal of rheumatology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3899/jrheum.2026-0574,
  title = {Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.},
  author = {Sung GCY and Au Yeung SL and Zhao SS},
  year = {2026},
  journal = {The Journal of rheumatology},
  doi = {10.3899/jrheum.2026-0574},
  url = {https://doi.org/10.3899/jrheum.2026-0574}
}

RIS

TY  - JOUR
TI  - Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.
AU  - Sung GCY
AU  - Au Yeung SL
AU  - Zhao SS
PY  - 2026
JO  - The Journal of rheumatology
DO  - 10.3899/jrheum.2026-0574
UR  - https://doi.org/10.3899/jrheum.2026-0574
ER  - 

APA

GCY, S., SL, A. Y., & SS, Z. (2026). Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.. The Journal of rheumatology. https://doi.org/10.3899/jrheum.2026-0574

Source records